{
  "url": "https://openlegislation.uk/food-for-specific-groups-food-for-special-medical-purposes-for-infants-infant-formula-and-follow-on-formula-information-and-compositional-requirements-amendment-etc-england-regulations-2020/regulation-5",
  "json_url": "https://openlegislation.uk/food-for-specific-groups-food-for-special-medical-purposes-for-infants-infant-formula-and-follow-on-formula-information-and-compositional-requirements-amendment-etc-england-regulations-2020/regulation-5.json",
  "legislation": "uksi/2020/43",
  "legislation_title": "The Food for Specific Groups (Food for Special Medical Purposes for Infants, Infant Formula and Follow-on Formula) (Information and Compositional Requirements) (Amendment etc.) (England) Regulations 2020",
  "legislation_url": "https://openlegislation.uk/food-for-specific-groups-food-for-special-medical-purposes-for-infants-infant-formula-and-follow-on-formula-information-and-compositional-requirements-amendment-etc-england-regulations-2020",
  "path": "regulation/5",
  "kind": "regulation",
  "number": "5",
  "heading": "Revocations, savings and transitional provisions relating to infant formula and follow-on formula",
  "text": "(1) The instruments specified in column 1 of the table in Schedule 3 are revoked to the extent specified in column 3 of that table, subject to paragraph (2).\n(2) The instruments specified in column 1 of the table in Schedule 3 continue to have effect (so far as otherwise revoked to the extent specified in column 3 of that table)—\n(a) until 21st February 2022 in respect of infant formula and follow-on formula manufactured from protein hydrolysates;\n(b) for the purposes of paragraph (3)(b).\n(3) Infant formula and follow-on formula which does not comply with a specified EU law requirement may continue to be marketed until stocks of such food are exhausted, provided that—\n(a) it was placed on the market or labelled—\n(i) before 22nd February 2020; or\n(ii) before 22nd February 2022 in the case of infant formula and follow-on formula manufactured from protein hydrolysates; and\n(b) the conditions specified in the following provision of the Infant Formula and Follow-on Formula (England) Regulations 2007 are met—\n(i) regulation 3(1) (prohibition on the marketing of infant formula unless certain conditions are met) in the case of infant formula;\n(ii) regulation 3(2) (prohibition on the marketing of follow-on formula unless certain conditions are met) in the case of follow-on formula.",
  "extent": "E+W",
  "status": null,
  "version": "current",
  "annotations": [
    {
      "type": "F",
      "label": "F1",
      "text": "Word in reg. 5(2)(a) substituted (21.2.2021) by The Nutrition (Amendment) and Food for Specific Groups (Food for Special Medical Purposes for Infants, Infant Formula and Follow-on Formula) (Information and Compositional Requirements) (Amendment) Regulations 2021 (S.I. 2021/168), regs. 1(2), 2(3)(a)"
    },
    {
      "type": "F",
      "label": "F2",
      "text": "Word in reg. 5(3)(a)(ii) substituted (21.2.2021) by The Nutrition (Amendment) and Food for Specific Groups (Food for Special Medical Purposes for Infants, Infant Formula and Follow-on Formula) (Information and Compositional Requirements) (Amendment) Regulations 2021 (S.I. 2021/168), regs. 1(2), 2(3)(b)"
    },
    {
      "type": "M",
      "label": "M1",
      "text": "S.I. 2007/3521, the relevant amending instrument is S.I. 2008/2445."
    },
    {
      "type": "I",
      "label": "I1",
      "text": "Reg. 5 in force at 22.2.2020, see reg. 1(1)"
    }
  ],
  "outstanding_effects": [],
  "provenance": {
    "source": "legislation.gov.uk",
    "source_url": "https://www.legislation.gov.uk/uksi/2020/43/regulation/5",
    "retrieved_at": "2026-10-28T22:34:38.864265+00:00"
  },
  "licence": "Open Government Licence v3.0",
  "licence_url": "https://www.nationalarchives.gov.uk/doc/open-government-licence/version/3/",
  "attribution": "Contains public sector information licensed under the Open Government Licence v3.0. Source: legislation.gov.uk, The National Archives."
}